0001415889-23-003199.txt : 20230223 0001415889-23-003199.hdr.sgml : 20230223 20230223165959 ACCESSION NUMBER: 0001415889-23-003199 CONFORMED SUBMISSION TYPE: 4 PUBLIC DOCUMENT COUNT: 1 CONFORMED PERIOD OF REPORT: 20230221 FILED AS OF DATE: 20230223 DATE AS OF CHANGE: 20230223 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: Zeldin Robert K CENTRAL INDEX KEY: 0001745347 FILING VALUES: FORM TYPE: 4 SEC ACT: 1934 Act SEC FILE NUMBER: 001-38520 FILM NUMBER: 23660675 MAIL ADDRESS: STREET 1: C/O ACCELERON PHARMA INC. STREET 2: 128 SIDNEY STREET CITY: CAMBRIDGE STATE: MA ZIP: 02139 ISSUER: COMPANY DATA: COMPANY CONFORMED NAME: MeiraGTx Holdings plc CENTRAL INDEX KEY: 0001735438 STANDARD INDUSTRIAL CLASSIFICATION: BIOLOGICAL PRODUCTS (NO DIAGNOSTIC SUBSTANCES) [2836] IRS NUMBER: 000000000 STATE OF INCORPORATION: E9 FISCAL YEAR END: 1231 BUSINESS ADDRESS: STREET 1: 450 EAST 29TH STREET STREET 2: 15TH FLOOR CITY: NEW YORK STATE: NY ZIP: 10016 BUSINESS PHONE: 6464902965 MAIL ADDRESS: STREET 1: 450 EAST 29TH STREET STREET 2: 15TH FLOOR CITY: NEW YORK STATE: NY ZIP: 10016 4 1 form4-02232023_090215.xml X0306 4 2023-02-21 0001735438 MeiraGTx Holdings plc MGTX 0001745347 Zeldin Robert K 450 EAST 29TH STREET 14TH FLOOR NEW YORK NY 10016 false true false false CHIEF MEDICAL OFFICER Stock Option (Right to Buy) 8.60 2023-02-21 4 A 0 30000 0 A 2033-02-21 Ordinary Shares 30000 30000 D Restricted Share Units 2023-02-21 4 A 0 30000 0 A Ordinary Shares 30000 30000 D The option vests as to one quarter of the total grant on February 21, 2024 and vests as to the remainder in 36 equal monthly installments thereafter. Each restricted share unit converts into one ordinary share upon vesting. Fifty percent of the restricted share unit award will vest on the second anniversary of the grant date and twenty-five percent of the restricted share unit award will vest on each of the third and fourth anniversaries of the grant date. /s/ Robert J. Wollin, Attorney-in-Fact for Robert K. Zeldin 2023-02-23